Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.
Stegmaier S, Leuschner I, Poremba C, Ladenstein R, Kazanowska B, Ljungman G, Scheer M, Blank B, Bielack S, Klingebiel T, Koscielniak E. Stegmaier S, et al. Among authors: bielack s. Pediatr Blood Cancer. 2017 Jan;64(1):89-95. doi: 10.1002/pbc.26206. Epub 2016 Sep 13. Pediatr Blood Cancer. 2017. PMID: 27621063
Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas.
Ozaki T, Schaefer KL, Wai D, Buerger H, Flege S, Lindner N, Kevric M, Diallo R, Bankfalvi A, Brinkschmidt C, Juergens H, Winkelmann W, Dockhorn-Dworniczak B, Bielack SS, Poremba C. Ozaki T, et al. Among authors: bielack ss. Int J Cancer. 2002 Dec 1;102(4):355-65. doi: 10.1002/ijc.10709. Int J Cancer. 2002. PMID: 12402305
Late effects surveillance system for sarcoma patients.
Langer T, Stöhr W, Bielack S, Paulussen M, Treuner J, Beck JD; German Late Effects Working Group in the German Society of Pediatric Oncology and Hematology. Langer T, et al. Among authors: bielack s. Pediatr Blood Cancer. 2004 Apr;42(4):373-9. doi: 10.1002/pbc.10325. Pediatr Blood Cancer. 2004. PMID: 14966836 Clinical Trial.
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K. Kempf-Bielack B, et al. Among authors: bielack ss. J Clin Oncol. 2005 Jan 20;23(3):559-68. doi: 10.1200/JCO.2005.04.063. J Clin Oncol. 2005. PMID: 15659502
Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
Paulides M, Kremers A, Stöhr W, Bielack S, Jürgens H, Treuner J, Beck JD, Langer T; German Late Effects Working Group in the Society of Pediatric Oncology and Haematology (GPOH). Paulides M, et al. Among authors: bielack s. Pediatr Blood Cancer. 2006 Apr;46(4):489-95. doi: 10.1002/pbc.20492. Pediatr Blood Cancer. 2006. PMID: 16333817
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System.
Paulides M, Dörr HG, Stöhr W, Bielack S, Koscielniak E, Klingebiel T, Jürgens H, Bölling T, Willich N, Sauer R, Langer T, Beck JD; Late Effects Surveillance System. Paulides M, et al. Among authors: bielack s. Clin Endocrinol (Oxf). 2007 May;66(5):727-31. doi: 10.1111/j.1365-2265.2007.02813.x. Epub 2007 Mar 23. Clin Endocrinol (Oxf). 2007. PMID: 17381483
275 results